Caribou Biosciences, Inc. (CRBU)
0.4602
-0.02
(-4.36%)
USD |
NASDAQ |
Oct 09, 16:00
0.4601
0.00 (0.00%)
After-Hours: 20:00
Caribou Biosciences 30-Day Average Daily Volume : 3.400M for Oct. 9, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 09, 2026 | 3.400M |
| October 08, 2026 | 3.106M |
| October 07, 2026 | 2.489M |
| October 06, 2026 | 1.285M |
| October 05, 2026 | 1.112M |
| October 02, 2026 | 1.099M |
| October 01, 2026 | 1.100M |
| September 30, 2026 | 1.129M |
| September 29, 2026 | 1.120M |
| September 28, 2026 | 1.130M |
| September 25, 2026 | 1.143M |
| September 24, 2026 | 1.151M |
| September 23, 2026 | 1.142M |
| September 22, 2026 | 1.152M |
| September 21, 2026 | 1.137M |
| September 18, 2026 | 1.138M |
| September 17, 2026 | 1.112M |
| September 16, 2026 | 1.107M |
| September 15, 2026 | 1.119M |
| September 14, 2026 | 1.109M |
| September 11, 2026 | 1.091M |
| September 10, 2026 | 1.040M |
| September 09, 2026 | 1.042M |
| September 08, 2026 | 1.048M |
| September 04, 2026 | 1.048M |
| Date | Value |
|---|---|
| September 03, 2026 | 1.036M |
| September 02, 2026 | 1.018M |
| September 01, 2026 | 1.027M |
| August 31, 2026 | 1.055M |
| August 28, 2026 | 1.060M |
| August 27, 2026 | 1.086M |
| August 26, 2026 | 1.117M |
| August 25, 2026 | 1.129M |
| August 24, 2026 | 1.215M |
| August 21, 2026 | 1.255M |
| August 20, 2026 | 1.332M |
| August 19, 2026 | 1.376M |
| August 18, 2026 | 1.454M |
| August 17, 2026 | 1.514M |
| August 14, 2026 | 1.519M |
| August 13, 2026 | 1.541M |
| August 12, 2026 | 1.560M |
| August 11, 2026 | 1.583M |
| August 10, 2026 | 1.644M |
| August 07, 2026 | 2.081M |
| August 06, 2026 | 2.109M |
| August 05, 2026 | 2.134M |
| August 04, 2026 | 2.166M |
| August 03, 2026 | 2.181M |
| July 31, 2026 | 2.219M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Intellia Therapeutics, Inc. | 4.943M |
| Vir Biotechnology, Inc. | 2.296M |
| Arrowhead Pharmaceuticals, Inc. | 2.142M |
| Oncolytics Biotech, Inc. | 1.076M |
| Sangamo Therapeutics, Inc. | 1.824M |